Skip to content
Stocks News
Enter Ticker Symbol
  • Home
  • FEATURED COMPANY
  • ANALYST COVERAGE
  • NEWS
  • SUBSCRIBE
  • CONTACT

ANALYST COVERAGE

amd-stock-rallies-as-bernstein analyst-raises-price-target

AMD Stock Rallies as Bernstein Analyst Raises Price Target

Jul 21, 2025

An error has occurred Your request was blocked by Link11 Web Application Security.If you believe this is the…

Read more
bridgebio-pharma-stock-(bbio)-opinions-on-analyst-buy-ratings-and-attruby-launch

BridgeBio Pharma Stock (BBIO) Opinions on Analyst Buy Ratings and Attruby Launch

Jul 21, 2025

By: Quiver DiscussionTracker Posted: an hour ago / July 21, 2025 5:01 p.m. UTC Recent discussions on X…

Read more
loop-capital-initiates-coverage-on-autodesk-stock-with-hold-rating-by-investing.com

Loop Capital initiates coverage on Autodesk stock with Hold rating By Investing.com

Jul 21, 2025

Loop Capital initiates coverage on Autodesk stock with Hold rating

Read more
expanding-analyst-interest-in-oryzon

Expanding Analyst Interest in ORYZON

Jul 21, 2025

New U.S. investment bank joins, bringing total coverage to ten analysts MADRID and CAMBRIDGE, Mass., July 21, 2025…

Read more
recent-analyst-ratings-forecast-further-upside-for-tat-technologies-ltd.-(tatt)

Recent Analyst Ratings Forecast Further Upside For TAT Technologies Ltd. (TATT)

Jul 21, 2025

Ashar Jawad Mon, Jul 21, 2025, 8:03 AM 2 min read In This Article: TAT Technologies Ltd. (NASDAQ:TATT)…

Read more
iqst-–-iqstel-issues-recap-shareholder-letter-highlighting-$2-debt-reduction-per-share,-$400-million-run-rate-in-q3-(ahead-of-schedule),-and-analyst-coverage-targeting-$18-$22-price-range

IQST – IQSTEL Issues Recap Shareholder Letter Highlighting $2 Debt Reduction Per Share, $400 Million Run Rate in Q3 (Ahead of Schedule), and Analyst Coverage Targeting $18-$22 Price Range

Jul 21, 2025

Company Recaps Milestones After Two Months onNASDAQ: Accelerated Growth, Strengthened Balance Sheet, Launch of High-Margin Tech Products, and…

Read more
this-alnylam-pharmaceuticals-analyst-begins-coverage-on-a-bullish-note;-here-are-top-5-initiations-for-monday-–-autodesk-(nasdaq:adsk),-albertsons-companies-(nyse:aci)

This Alnylam Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday – Autodesk (NASDAQ:ADSK), Albertsons Companies (NYSE:ACI)

Jul 21, 2025

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst…

Read more
truist-securities-initiates-biogen-stock-coverage-with-hold-rating-by-investing.com

Truist Securities initiates Biogen stock coverage with Hold rating By Investing.com

Jul 21, 2025

Truist Securities initiates Biogen stock coverage with Hold rating

Read more
recent-analyst-ratings-forecast-further-upside-for-tat-technologies-ltd.-(tatt)

Recent Analyst Ratings Forecast Further Upside For TAT Technologies Ltd. (TATT)

Jul 21, 2025

TAT Technologies Ltd. (NASDAQ:TATT) is among the 10 Best Small Cap Defense Stocks to Buy According to Hedge…

Read more
barclays-initiates-coverage-on-sprouts-farmers-market-stock-with-equalweight-rating-by-investing.com

Barclays initiates coverage on Sprouts Farmers Market stock with Equalweight rating By Investing.com

Jul 21, 2025

Barclays initiates coverage on Sprouts Farmers Market stock with Equalweight rating

Read more
bernstein-initiates-coverage-on-tenaris-stock-with-outperform-rating-by-investing.com

Bernstein initiates coverage on Tenaris stock with Outperform rating By Investing.com

Jul 21, 2025

Bernstein initiates coverage on Tenaris stock with Outperform rating

Read more
citi-initiates-coverage-on-ralliant-stock-with-neutral-rating-by-investing.com

Citi initiates coverage on Ralliant stock with Neutral rating By Investing.com

Jul 21, 2025

Citi initiates coverage on Ralliant stock with Neutral rating

Read more
  1. Pages:
  2. «
  3. 1
  4. ...
  5. 242
  6. 243
  7. 244
  8. 245
  9. 246
  10. 247
  11. 248
  12. ...
  13. 450
  14. »

Posts pagination

Newer posts Page 1 … Page 245 … Page 450 Older posts

The content presented on this site is intended solely for entertainment purposes and should not be construed as an invitation to engage in the purchase or sale of securities. Each content provider featured on 10x Wealth Report brings a unique perspective and predisposition, which may not necessarily align with that of 10x Wealth Report. It is crucial to recognize that 10x Wealth Report is not a registered financial advisor or firm. Read More full disclaimer

CATEGORIES

  • FEATURED COMPANY
  • NEWS
  • ANALYST COVERAGE
  • Special Post
  • CONTACT
  • SUBSCRIBE
  • Privacy Policy
  • Terms or Service
  • Disclaimer

CONNECT & FOLLOW

© 10x Wealth Report Copyright 2024.